Envoy Medical, Inc. (COCH) IPO - S-1 Filing, Stock & Insider Activity
Envoy Medical, Inc. IPO - Status & S-1 Filing
- Ticker: COCH
- Status: Registered - S-1 filed with the SEC
- S-1 filed: 2025-12-01
- Exchange: NASDAQ
- Expected price range: not yet disclosed (set in a later S-1/A or pricing amendment)
- Shares offered: 28,301,886
- SEC CIK: 0001840877 · View the S-1 on SEC EDGAR →
Track every registration update on the InsiderAlpha IPO tracker.
Last SEC filing
Envoy Medical, Inc. (COCH) has filed 2 SEC Form 4 insider transactions in the last 90 days, with the most recent on 2026-06-23. 5 Form 8-K material event filings were reported by COCH in the last 90 days. InsiderAlpha tracks every COCH SEC filing - Form 4, Form 144, and 8-K - in real time, including Rule 10b5-1 plan detection.
About Envoy Medical, Inc. (COCH)
Envoy Medical, Inc. trades under the ticker COCH. InsiderAlpha tracks 25 primary SEC Form 4 filings from 10 reporting insiders for COCH since 2024, sourced directly from SEC EDGAR.
| Sector | Health Care insider trading |
|---|---|
| SIC classification | Orthopedic, Prosthetic & Surgical Appliances & Supplies (SIC 3842) |
| SEC CIK | 0001840877 |
90-Day SEC Filing Activity
| Form 4 filings (90d) | 2 |
|---|---|
| Form 8-K filings (90d) | 5 |
| Latest Form 4 filing | 2026-06-23 |
Recent COCH Insider Transactions (Form 4)
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Brent T. Lucas | Chief Executive Officer | A - Grant or award | 32.9K | $0.60 | $20K | SEC | |
| Glen A. Taylor | 10% Owner | P - Open-market purchase | 18.75M | $0.40 | $7.50M | SEC | |
| Mona Chetan Patel | Director | P - Open-market purchase | 312.5K | $0.40 | $125K | SEC | |
| Robert Potashnick | Interim CFO | P - Open-market purchase | 212.5K | $0.40 | $85K | SEC | |
| Susan Kantor | Director | P - Open-market purchase | 96.2K | $0.40 | $38K | SEC | |
| Charles Brynelsen | Director | P - Open-market purchase | 1.00M | $0.40 | $400K | SEC | |
| Brent T. Lucas | Chief Executive Officer | P - Open-market purchase | 62.5K | $0.40 | $25K | SEC | |
| Anzu SPAC GP I LLC | Insider | J - Other acquisition / disposition | 2.03M | $0.00 | - | SEC | |
| Susan Kantor | Insider | J - Other acquisition / disposition | 34.7K | $0.00 | - | SEC | |
| Anzu SPAC GP I LLC | Insider | J - Other acquisition / disposition | 1.03M | $0.00 | - | SEC | |
| Mona Chetan Patel | Director | P - Open-market purchase | 2.5K | $2.28 | $6K | SEC | |
| Susan Kantor | Director | J - Other acquisition / disposition | 18.2K | $0.00 | - | SEC | |
| Anzu SPAC GP I LLC | 10% Owner | J - Other acquisition / disposition | 1.00M | $0.00 | - | SEC |
All transactions sourced from SEC EDGAR Form 4 filings for Envoy Medical, Inc. (COCH). Updated in real time as new filings are submitted to the SEC.
Most-Active COCH Insiders - Last 90 Days
| Insider | Form 4 filings | Total transaction value |
|---|---|---|
| Brent T. Lucas | 3 | $20K |
Recent COCH Form 8-K Material Events
- - Item 1.02, 9.01 [SEC]
- - Item 5.02, 9.01 [SEC]
- - Item 3.01 [SEC]
- - Item 5.02, 5.07, 9.01 [SEC]
- - Item 2.02, 9.01 [SEC]
Recent Insider Filings
- - Brent T. Lucas (Chief Executive Officer)
- - Brent T. Lucas (Chief Executive Officer)
- - Chas McKhann (Director)
- - Mona Chetan Patel (Director)
- - Robert Potashnick (Interim CFO)
Form 4 Transaction Code Reference
SEC Form 4 transactions are reported with a one-letter code indicating the type of transaction. Common codes you'll see in COCH insider filings:
| P | Open-market purchase by the insider |
|---|---|
| S | Open-market sale by the insider |
| A | Grant, award, or other acquisition from the issuer |
| M | Exercise or conversion of derivative security (e.g. options) |
| F | Payment of exercise price or tax liability via share withholding |
| G | Bona-fide gift of securities |
| D | Disposition to the issuer (e.g. share buyback participation) |
| J | Other acquisition or disposition |
| X | Exercise of in-the-money or at-the-money derivative security |
| C | Conversion of derivative security |
| V | Transaction voluntarily reported earlier than required |
COCH Insider Trading - FAQ
- What is the latest insider trade for COCH?
- Envoy Medical, Inc. (COCH) had 2 insider filings in the last 90 days, with the most recent on 2026-06-23. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
- How many insiders are buying COCH stock?
- 0 insider purchases of COCH were filed in the last 90 days.
- How many insiders are selling COCH stock?
- 0 insider sales of COCH were filed in the last 90 days.
- Where can I see COCH SEC filings (Form 4, 10-K, 10-Q, 8-K)?
- This page tracks COCH Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care Companies with Insider Activity
Other companies in the InsiderAlpha index with a significant SEC Form 4 insider-trading footprint:
- $COGT Cogent Biosciences, Inc.
- $CRSP CRISPR Therapeutics AG
- $CTTH CTT PHARMACEUTICAL HOLDINGS, INC.
- $CV CapsoVision, Inc
- $CVKD Cadrenal Therapeutics, Inc.
- $CVM CEL SCI CORP
- $DMAC DiaMedica Therapeutics Inc.
- $EDGM Edgemode, Inc.
- $ERNA Ernexa Therapeutics Inc.
- $ETNB 89bio, Inc.
Related Companies - Recent Insider Activity
- Edwards Lifesciences Corp (EW)
- STERIS plc (STE)
- MYOMO, INC. (MYO)
- LAKELAND INDUSTRIES INC (LAKE)
- ZIMMER BIOMET HOLDINGS, INC. (ZBH)
- ESTABLISHMENT LABS HOLDINGS INC. (ESTA)
- Enovis CORP (ENOV)
- MSA Safety Inc (MSA)
- AVANOS MEDICAL, INC. (AVNS)
- INTUITIVE SURGICAL INC (ISRG)
Learn More
- What is SEC Form 4?
- How to read insider buying signals
- Rule 10b5-1 trading plans explained
- The cluster buying signal
Open the live COCH dashboard on InsiderAlpha for real-time alerts, charting, and full historical filing search.